ロード中...

BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV

Infection with Kaposi sarcoma-associated herpesvirus (KSHV) is estimated to account for over 44,000 new cases of Kaposi sarcoma annually, with 84% occurring in Africa, where the virus is endemic. To date, there is no prophylactic vaccine against KSHV. KSHV gpK8.1, gB, and gH/gL glycoproteins, implic...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Barasa, Anne K, Ye, Peng, Phelps, Meredith, Arivudainambi, Ganapathiram T, Tison, Timelia, Ogembo, Javier Gordon
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5470984/
https://ncbi.nlm.nih.gov/pubmed/28404899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15605
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!